Physician profile
Johnny L Serrano
NPI 1578547857
$10,774.54
in general payments reported to CMS, 2019-2025
29 companies · $1,278 in 2025
The $1,278 reported for 2025 was more than what 75% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,226 · 2020: $66.56 · 2021: $323 · 2022: $6,299 · 2023: $823 · 2024: $759 · 2025: $1,278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,541 · Travel and Lodging: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,541.35 |
| Travel and Lodging | $318.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,467.94 | 2022-2025 | |
| Tela Bio, INC. | $1,801.09 | 2020-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Allergan, INC. | $823.86 | 2019-2021 | |
| Medtronic, INC. | $597.42 | 2022-2025 | Intellis Adaptivestim, Synchromedii, Interstim |
| Novo Nordisk INC | $459.11 | 2019-2025 | Wegovy |
| Stryker Corporation | $318.12 | 2023 | 1688 |
| Boston Scientific Corporation | $305.98 | 2019-2024 | Varithena Administration Pack |
| Acadia Pharmaceuticals INC | $224.33 | 2021-2024 | Daybue |
| Edwards Lifesciences Corporation | $160.82 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Pacira Pharmaceuticals Incorporated | $152.45 | 2019-2022 | |
| Inspire Medical Systems, INC. | $144.67 | 2025 | Inspire |
| Biosense Webster, INC. | $144.65 | 2025 | Carto 3 |
| Madrigal Pharmaceuticals | $125.51 | 2025 | Rezdiffra |
| Amgen INC. | $122.15 | 2025 | Otezla |
| Eisai INC. | $121.81 | 2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $118.38 | 2021-2023 | Phasix Mesh |
| Teva Pharmaceuticals USA, INC. | $117.93 | 2022 | |
| Innocoll Pharmaceuticals Limited | $116.66 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $116.65 | 2019-2025 | Bridion |
| Shire North American Group INC | $115.99 | 2019 | |
| Olympus Corporation of The Americas | $65.00 | 2023 | Itind System |
| Penumbra, INC. | $33.76 | 2025 | Indigo System |
| Bard Peripheral Vascular, INC. | $25.31 | 2022-2023 | Venclose Maven Catheter |
| Kci USA, INC. | $18.47 | 2021 | |
| Advanced Oxygen Therapy INC. | $17.55 | 2025 | Topical Oxygen Chamber For Extremities |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $17.17 | 2025 | |
| Northgate Technologies, INC. | $16.28 | 2023 | Smoke Removel - Nebulae |
| Ethicon US, LLC | $12.85 | 2021 | |
| Acell, INC. | $12.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnny Serrano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.